Merit Medical Reports Second Quarter 2024 Results and Raises Full-Year Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Merit Medical Systems, Inc. (MMSI) PT Raised to $92 at BofA Securities
August 5, 2024 5:43 AM EDTBofA Securities analyst Craig Bijou raised the price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $92.00 (from $87.00) while maintaining a Neutral rating.
The analyst comments "Merit Medical (MMSI) reported Q2 revenue at the end of last week. Q2 revenue of $338m (+5% y/y organic) beat... More
Merit Medical Systems Inc. (MMSI) Tops Q2 EPS by 5c, Beats on Revenue; Offers FY24 Guidance
August 1, 2024 4:19 PM EDTMerit Medical Systems Inc. (NASDAQ: MMSI) reported Q2 EPS of $0.92, $0.05 better than the analyst estimate of $0.87. Revenue for the quarter came in at $338 million versus the consensus estimate of $334.54 million.
GUIDANCE:
Merit Medical Systems Inc. sees FY2024 EPS of... More
